In 2021 the company made a revenue of $9.75 M an increase over the years 2020 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | N/A | -100% |
2021 | $9.75 M | |
2020 | N/A | |
2019 | N/A | -100% |
2018 | $22.25 M | -14.26% |
2017 | $25.95 M | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Gilead Sciences GILD | $27.11 B | N/A | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | $0.10 B | N/A | ๐บ๐ธ USA |
Aeterna Zentaris AEZS | $4.49 M | N/A | ๐บ๐ธ USA |